Moderna says the FDA will consider its new flu shot after resolving a public dispute
WASHINGTON (AP) — The Food and Drug Administration volition see whether to o.k. Moderna’s caller flu vaccine aft all, resolving a quality that had blocked the company’s exertion for the first-of-its-kind shot. Moderna announced the alteration Wednesday, astir a week aft revealing that the FDA’s vaccine main was refusing to reappraisal the caller vaccine, made [...]





